QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

HTGC

QT73Hercules Capital, Inc.
NYSE·Financial Services·Asset Management·USA
Latest market price
15.49
+0.08+0.52%
OverviewShort InterestFilings
HTGCQT73Hercules Capital, Inc.·NYSE
OverviewShort InterestFilings
15.49+0.52%
TA
Loading chart...
Screen all →
BLK-0.69%$1050.09BX-0.98%$123.79BK-1.03%$142.50BN-0.67%$44.44KKR-0.16%$97.01APO-1.01%$137.50APOS+0.08%$25.60BAM-1.13%$47.44
Snapshot
Index-P/E8.59EPS (ttm)1.77
Insider Own2.28%
Shs Outstand187.12M
Perf Week-0.13%
Market Cap2.88BForward P/E7.85EPS next Y1.97Insider Trans0.10%Shs Float-Perf Month1.18%
Enterprise Value5.43BPEG0.23EPS next Q0.50Inst Own-Short Float-Perf Quarter7.42%
Income339.89MP/S5.30EPS this Y8.77%Inst Trans-Short Ratio-Perf Half Y-17.21%
Sales550.62MP/B1.28EPS next Y2.51%ROA6.88%Short Interest-Perf YTD-17.69%
Book/sh11.90P/C-EPS next 5Y-0.36%ROE15.11%52W High19.67 -21.25%Perf Year-12.98%
Cash/sh0.22P/FCF-EPS past 3/5Y-ROIC7.47%52W Low13.70 13.07%Perf 3Y-
Dividend Est.1.95 (12.59%)EV/EBITDA15.19Sales past 3/5Y31.78% 8.91%Gross Margin85.78%Volatility1.05% 1.35%Perf 5Y-
Dividend TTM1.95 (12.59%)EV/Sales9.87EPS Y/Y TTM21.12%Oper. Margin64.90%ATR (14)0.31Perf 10Y-
Dividend Ex-DateMay 14, 2026Quick Ratio0.94Sales Y/Y TTM27.84%Profit Margin60.28%RSI (14)49.25Recom2.50
Dividend Gr. 3/5Y1.99% 8.66%Current Ratio0.94EPS Q/Q6.67%SMA200.12%Beta0.64Target Price16.50
Payout99.89%Debt/Eq1.15Sales Q/Q4.35%SMA50-0.89%Rel Volume0.99Prev Close15.41
Employees100LT Debt/Eq1.04EarningsJul 30SMA200-8.67%Avg Volume1.74MPrice15.49
IPO DateJun 09, 2005Option/ShortYes / YesEPS/Sales Surpr.2.13% 0.71%Net Debt/EBITDA7.02Volume1,730,166Change0.52%
Analyst Ratings
DateActionAnalystRatingTarget
May-18-26ReiteratedUBSNeutral$19 → $16
Feb-13-26DowngradePiper SandlerOverweight → Neutral$21 → $18
Dec-15-25InitiatedLucid CapitalBuy$20
Nov-04-25UpgradeCompass PointNeutral → Buy$20
Oct-14-25ReiteratedUBSNeutral$20 → $19
Oct-09-25ReiteratedPiper SandlerOverweight$22 → $21
Dec-12-24UpgradeKeefe, Bruyette & WoodsMarket Perform → Outperform
Jul-18-24ReiteratedUBS$19 → $20
Jul-10-24ReiteratedPiper SandlerOverweight$22
May-03-24ReiteratedPiper SandlerOverweight$21 → $22
Latest News
Jun-13-26
Jun-13-2606:53AM
What Moved Markets This WeekSeekingAlpha
Jun-12-26
Jun-12-2608:58PM
Main Street Capital: Buy The Dip In The Best BDC On The MarketSeekingAlpha
Jun-10-26
Jun-10-2609:06AM
Beren Therapeutics Secures $300M In Combined Financing With Hercules Capital To Support Investments In Commercial Readiness Activities For Adrabetadex Ahead Of November 17 PDUFA Target Action DateBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue551547431
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A787077
Gross Profit473477354
Selling, General and Administrative Excl. Other191920
Research and Development
000
Other Operating Expense959371
Operating Income358365263
Interest Expense1009277
Unusual Expense
———
Non-Operating Income (Expense)
000
Net Income Before Taxes333340263
Income Taxes
000
Consolidated Net Income333340263
Net Income From Continuing Operations333340263
Net Income333340263
EPS (Recurring)1.831.901.61
EPS (Basic, Before Extraordinaries)1.831.901.61
EPS (Diluted)1.771.851.61
EBITDA358365263
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio8.7510.17—
Price To Sales Ratio5.146.23—
Gross Margin85.8487.2082.13
Operating Margin64.9766.7361.02
Net Margin60.4462.1661.02
Shares Outstanding183181161
Market Capitalization2,8353,406—
Operating Lease Expense
———
Insider Trading Volume
$18.23$16.80$15.37$13.93$12.50● Close Price0.00M0.46M0.93M1.39M1.85MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
CROWELL GAYLE ADirectorMar 26 '26Buy14.357,317104,99997,589Mar 30 12:00 AM
BADAVAS ROBERT PDirectorMar 26 '26Buy14.353,65852,4925,070Mar 30 12:00 AM
Loo WadeDirectorMar 26 '26Buy14.357,317104,99914,050Mar 30 12:00 AM
Fallon Thomas JDirectorMar 26 '26Buy14.307,300104,390157,669Mar 30 12:00 AM
Aguirre DeAnneDirectorMar 26 '26Buy14.357,317104,99910,749Mar 30 12:00 AM
Randhawa Paramjeet KDirectorMar 26 '26Buy14.352,92641,98822,486Mar 30 12:00 AM
Theodosopoulos NikosDirectorMar 26 '26Buy14.357,317104,99929,362Mar 30 12:00 AM
Follmann ChristianChief Operating OfficerMar 04 '26Buy14.6810,000146,800150,135Mar 05 12:00 AM
Randhawa Paramjeet KDirectorMar 04 '26Buy14.783,05045,07919,560Mar 05 12:00 AM
Theodosopoulos NikosDirectorFeb 27 '26Buy14.212,60036,94621,523Feb 27 12:00 AM
BADAVAS ROBERT PDirectorFeb 27 '26Buy14.275,00071,350122,073Feb 27 12:00 AM
Botelho Kiersten ZazaChief Legal Officer & CCOFeb 27 '26Buy14.211,30018,47393,336Feb 27 12:00 AM
Fallon Thomas JDirectorFeb 27 '26Buy14.2020,000284,000150,369Feb 27 12:00 AM
Meyer Seth HChief Financial OfficerFeb 27 '26Buy14.337,000100,310448,553Feb 27 12:00 AM
Bluestein ScottChief Executive OfficerFeb 27 '26Buy14.357,000100,4502,516,379Feb 27 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR